` 601607 (Shanghai Pharmaceuticals Holding Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

601607
vs
S
Shanghai Composite

Over the past 12 months, Shanghai Pharmaceuticals Holding Co Ltd has underperformed Shanghai Composite, delivering a return of -11% compared to Shanghai Composite's 2% drop.

Stocks Performance
601607 vs Shanghai Composite

Loading...
601607
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
601607 vs Shanghai Composite

Loading...
601607
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
601607 vs Shanghai Composite

Loading...
601607
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Shanghai Pharmaceuticals Holding Co Ltd vs Peers

Shanghai Composite
601607
MCK
COR
CAH
SIG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Shanghai Pharmaceuticals Holding Co Ltd
Glance View

Market Cap
60.1B CNY
Industry
Health Care

Shanghai Pharmaceuticals Holding is a Chinese healthcare company that does two main jobs: it makes medicines and it distributes them. On the manufacturing side, it develops and produces prescription drugs, over-the-counter products, and traditional Chinese medicine products. On the distribution side, it moves medicines and healthcare products through hospitals, retail pharmacies, and other medical channels. The company sells to a broad set of customers, including hospitals, drug stores, clinics, and other healthcare providers, as well as consumers who buy medicines through pharmacies and other retail outlets. It also works with drug makers and medical suppliers that need a large distribution network to get products to end users. Most of its money comes from selling pharmaceutical products and earning distribution and supply-chain fees. What makes Shanghai Pharmaceuticals different is that it sits in both parts of the drug value chain. Many companies either make medicines or distribute them, but Shanghai Pharmaceuticals does both. That gives it a large role in getting medicines from factories to patients, and it helps the company benefit from steady demand for essential healthcare products.

Intrinsic Value
¥28.29
Undervaluation 43%
Intrinsic Value
Price ¥16.22
Back to Top